Inari Medical Q4 EPS $(0.08) Misses $0.01 Estimate, Sales $132.09M Beat $131.79M Estimate
Portfolio Pulse from Benzinga Newsdesk
Inari Medical reported Q4 earnings with a loss of $(0.08) per share, missing the analyst consensus estimate of $0.01. However, their quarterly sales of $132.09M exceeded the estimate of $131.79M, marking a 22.57% increase from the previous year.
February 28, 2024 | 9:06 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Inari Medical's Q4 earnings showed a miss on EPS but a beat on revenue, with sales growing 22.57% compared to last year.
The mixed results with a significant miss on EPS but a slight beat on revenue forecasts could lead to neutral short-term stock price movement. The revenue growth indicates strong sales performance, which might offset concerns about the earnings miss to some extent.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100